Do celebrities actually use Ozempic? Separating Oscar rumors from GLP-1 facts

What did @joysparkleshine actually say?

The creator looked at several women on the 2026 Oscar red carpet and argued, essentially, that GLP-1 drugs like Ozempic are making Hollywood dangerously thin. She said one celebrity's "body is so small that her head looks too big for it," called the drugs "poisons," and suggested stylists were scrambling last-minute to hide "too bony" shoulders. She also claimed Demi Moore made comments about never showing her back again because of her appearance. The disclaimer at the end of the caption says this is "entertainment" and "no facts" — but nearly a million people watched it, and the framing was presented as genuine concern, not satire.

None of the named celebrities have publicly confirmed using semaglutide or any GLP-1 medication. Attributing their bodies to Ozempic is speculation dressed as observation.

Does the science back this up?

There is real, documented evidence that GLP-1 receptor agonists cause significant weight loss, including muscle loss, which can produce a gaunt appearance. That part is grounded in data. The problem is the leap from "she looks thin" to "she's on Ozempic" to "she has an eating disorder."

A 2021 trial published in the New England Journal of Medicine (Wilding et al.) found that semaglutide produced an average 14.9% body weight reduction over 68 weeks in adults with obesity. A meaningful portion of that loss is lean mass, not just fat. Daly et al. (2022, Obesity) confirmed that without resistance training, roughly 25-39% of weight lost on GLP-1 therapy can come from muscle. So yes, people on these drugs can look thin in ways that concern clinicians. But that is not the same as saying every thin celebrity is on Ozempic, or that thinness at the Oscars is proof of drug use or disordered eating. The creator conflates visible collarbone with clinical pathology, which is not a diagnostic standard anyone uses.

What did they get wrong (or right)?

They got one thing approximately right: clinicians do have legitimate concerns about muscle wasting and a "skinny fat" body composition in patients using GLP-1 drugs without adequate protein intake and exercise. That concern is real and published.

But nearly everything else in the video is either unverifiable or misleading. Calling semaglutide a "poison" is inaccurate. The FDA approved semaglutide for chronic weight management in adults (Wegovy, 2021) and for type 2 diabetes (Ozempic, 2017) based on large randomized controlled trials. The word "poison" implies toxicity without therapeutic window, which is not supported by the safety profile in the literature.

The claim that these celebrities are using Ozempic is pure speculation. The creator offers no sourcing. Linking visible thinness to eating disorders in named individuals without any clinical basis is irresponsible, even under an "entertainment" disclaimer. Naming Maude Apatow and others while implying eating disorder behavior based on appearance alone is the kind of content that researchers say reinforces harmful body image comparisons. Rodgers et al. (2020, International Journal of Eating Disorders) found that social media content linking thinness to celebrity drug use increases disordered eating cognitions in adolescent viewers.

What should you actually know?

GLP-1 drugs produce real, significant weight loss. They also carry real risks that are worth discussing seriously, not spectacularly. Muscle loss, nausea, pancreatitis risk, and potential thyroid concerns are all documented in peer-reviewed literature and listed in FDA labeling. Those are conversations worth having.

What is not worth having is a nearly million-view video that diagnoses celebrities with eating disorders by looking at their collarbones on a red carpet. The creator says she's sad these women "fill their bodies full of poisons" — but the video itself does something arguably more harmful. It packages appearance-based speculation as health concern, gives it a medical-sounding label (Ozempic, ED), and sends it to a predominantly young female audience. A 2023 study by Rodgers and Melioli in Body Image found that exposure to celebrity weight-loss content is associated with increased body dissatisfaction in women aged 18-35, regardless of whether the content is framed as concern or criticism. The framing of sympathy does not neutralize the impact.

If you are genuinely concerned about your own weight, metabolism, or relationship with food, that conversation belongs with a licensed clinician, not a TikTok comment section.